DexCom (DXCM) PT Raised to $270 at Morgan Stanley
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $88.76 -1.1%
Rating Summary:
32 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Rating Summary:
32 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Join SI Premium – FREE
Morgan Stanley analyst David Lewis raised the price target on DexCom (NASDAQ: DXCM) to $270.00 (from $225.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- JD Health International Inc (6618:HK) PT Lowered to HK$60 at Nomura/Instinet
- Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
